Search - tctmd.com

Displaying 1 - 20 of 158

Sort: Relevancy | Date

News Conference News AHA 2016

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

L.A. McKeown

November 17, 2016

News Conference News TCT 2016

Transcaval TAVR Presents New Option for Patients With Complex Anatomy

Yael L. Maxwell

October 29, 2016

News Daily News

Fallout From Rehospitalization After Acute MI May Extend Beyond Economics

Yael L. Maxwell

October 28, 2016

News Features

A Dose for Doing: Healthcare Providers and Exercise Specialists Struggle With Prescribing Physical Activity

Yael L. Maxwell

October 24, 2016

News Daily News

New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk

Todd Neale

September 29, 2016

News Conference News PCR London Valves 2016

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Shelley Wood

September 20, 2016

News Daily News

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Yael L. Maxwell

August 10, 2016

News Daily News

Updated ACTION-GWTG Risk Score Aims to Better Predict In-Hospital Mortality After Acute MI

Yael L. Maxwell

August 03, 2016

News Daily News

La Escala de Riesgo Actualizada de ACTION-GWTG Pretende Predecir Mejor la Mortalidad Intrahospitalaria Post-IAM

Yael L. Maxwell

August 03, 2016

News Daily News

Public Reporting Should Focus on Institutions or Teams, Not Individuals, CV Surgeons Say

L.A. McKeown

July 13, 2016

News Daily News

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

Michael O'Riordan

June 30, 2016

News Daily News

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Michael O'Riordan

June 30, 2016

News Features

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

Todd Neale

June 27, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

News Daily News

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Shelley Wood

June 07, 2016

News Daily News

La ATC es Parecida tanto Clínica como Económicamente a las Pruebas Funcionales para Descartar EAC

Leah Lawrence

May 25, 2016

News Daily News

CTA Both Clinically, Economically Comparable to Functional Testing for Suspected CAD

Leah Lawrence

May 25, 2016

News Daily News

Statins Tied to Lower Mortality, Amputation Risks in PAD

Michael O'Riordan

May 09, 2016

News Industry News

CardioCell Completes Enrollment for a Phase IIa Clinical Trial Using Its Stem Cells for Participants With Chronic Heart Failure

April 19, 2016

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Shelley Wood

April 08, 2016

Advertisement

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

Transcaval TAVR Presents New Option for Patients With Complex Anatomy

Fallout From Rehospitalization After Acute MI May Extend Beyond Economics

A Dose for Doing: Healthcare Providers and Exercise Specialists Struggle With Prescribing Physical Activity

New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Updated ACTION-GWTG Risk Score Aims to Better Predict In-Hospital Mortality After Acute MI

La Escala de Riesgo Actualizada de ACTION-GWTG Pretende Predecir Mejor la Mortalidad Intrahospitalaria Post-IAM

Public Reporting Should Focus on Institutions or Teams, Not Individuals, CV Surgeons Say

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

La ATC es Parecida tanto Clínica como Económicamente a las Pruebas Funcionales para Descartar EAC

CTA Both Clinically, Economically Comparable to Functional Testing for Suspected CAD

Statins Tied to Lower Mortality, Amputation Risks in PAD

CardioCell Completes Enrollment for a Phase IIa Clinical Trial Using Its Stem Cells for Participants With Chronic Heart Failure

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content